A consecutive series of 50 patients with malignant biliary obstruction were treated by means of palliative drownage with a metallic expandable stent. Stem placement was successful in all patients. The patients were followed up prospectively at 2-month intervals over a period of 9-22 months. Forty-one patients (82%) died; nine (18%) are still living.
The overall patency and survival rates for the 50 patients were 5.8 months and 7.5 months, respectively. The 30-day mortality rate was 8% (n 4), the minor complication rate was 18% (n 9), and the major complication rate was 8% (n 4). One patient (2%) had intrahepatic arterial bleeding that required ernbolization, one (2%) had a right subphrenic abscess, and two patients (4%) had transient septic events. Stem occlusion requiring a second intervention occurred in 24% of patients (n--12) . Excellent 12 .9-fold (P < 0.001), esophageal perforation 6.4-fold (P < 0.005), and postsclerotherapy bleeding esophageal ulcers 3.7-fold (P < 0.001) in those receiving emergency sclerotherapy as opposed to prophylactic sclerotherapy. These differences were even greater if the number of sclerotherapy sessions rather than the number of patients was used as the denominator for the comparisons. In total, 19.6% of emergency sclerotherapy cases were associated with an untoward outcome of sclerotherapy; only 1.9% of cases receiving prophylactic sclerotherapy experienced an untoward outcome (P < 0.001). These data demonstrate that leinergency sclerotherapy is associated with a greater prevalence of complications and support earlier studies that show that sclerotherapy
